Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

33.65
-0.3282-0.97%
Post-market: 33.51-0.1404-0.42%16:10 EDT
Volume:3K
Turnover:102.82K
Market Cap:13.46M
PE:- -
High:33.77
Open:33.77
Low:33.14
Close:33.98
52wk High:34.98
52wk Low:27.25
Shares:400.00K
Float Shares:400.00K
Volume Ratio:1.96
T/O Rate:0.77%
Dividend:0.08
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study

TIPRANKS
·
Oct 02

Johnson & Johnson Says Icotyde Sustains Psoriasis Skin Clearance Through 2 Years in Phase 3 Iconic-TOTAL Study

Reuters
·
Oct 02

J&J - Icotyde-Treated Patients Show 70% Clear or Almost Clear Skin at Week 112

THOMSON REUTERS
·
Oct 02

Johnson & Johnson Announces New Icotyde® (Icotrokinra) Data in Difficult-to-Treat Plaque Psoriasis with Proven Durability Through 2-Years, Affirming Its Use as a Powerful First Line Systemic Therapy~

THOMSON REUTERS
·
Oct 02

J&J - 60% Scalp Psoriasis, 89% Genital Psoriasis Patients Achieve Complete Clearance at Week 112

THOMSON REUTERS
·
Oct 02

J&J - Safety Findings Through Week 112 Consistent with Icotyde Profile, no New Safety Signals

THOMSON REUTERS
·
Oct 02

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Oct 02

Novartis Strikes up to $7.8 Billion mRNA Deal with China's Abogen

Reuters
·
Oct 02

More Upside Awaits for Gilead Sciences Stock. Stay Invested.

Dow Jones
·
Oct 02

PRECISE and AWS to build systems for Singapore's 450,000-person genomics study

Nurdianah Md Nur
·
Oct 02

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Oct 02

Biogen Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Oct 02

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Oct 02

Edwards Lifesciences Receives FDA Approval for Autus Valve, the First Surgical Pulmonary Valve for Pediatric Patients

THOMSON REUTERS
·
Oct 02

US FDA - Approves Autus Size-Adjustable Valve for Pediatric Congenital Pulmonary Valve Disease

THOMSON REUTERS
·
Oct 02

US FDA - Edwards Lifesciences Receives FDA Approval for Autus Size-Adjustable Valve

THOMSON REUTERS
·
Oct 02

Merck's Tulisokibart Data From Hidradenitis Suppurativa Trial Looks Solid, UBS Securities Says

MT Newswires Live
·
Oct 02

Oxford BioDynamics Extends Vulpes Payment Deadline in £9.15m Placing

TIPRANKS
·
Oct 01

Gilead Sciences Announces Dividend of R$ 0.2394442440 Per Unit for Brgildbdr 000

Reuters
·
Oct 01

Veeva supporting transformation of medicine through AI, Barron’s reports

TIPRANKS
·
Oct 01